<DOC>
	<DOCNO>NCT02117115</DOCNO>
	<brief_summary>Contrast-enhanced abdominal CT perform 1-2 week allogeneic stem cell transplant , radiographic evidence mucosal inflammation correlate subsequent development acute graft versus host disease . The primary endpoint feasibility safety contrast-enhanced abdominal CT early post-transplant period , define risk contrast-related nephropathy allergic reaction .</brief_summary>
	<brief_title>Abdominal CT Predict Risk Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<criteria>Biopsyproven diagnosis hematologic malignancy Scheduled undergo allogeneic SCT match sibling donor unrelated donor 10/10 9/10 HLA match . Transplant eligibility per standard institutional criterion . Age 1860 year Willing able provide inform consent Documented report contrast allergy Estimated glomerular filtration rate ( GFR ) &lt; 60 Deemed sick clinician leave floor image `` Nothingpermouth '' status clinical reason Inclusion Women Minorities Both men woman member race ethnic group eligible trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>